Netanyahu Reveals Prostate Cancer, Underwent Radiation Therapy
Netanyahu Reveals Prostate Cancer, Underwent Radiation Therapy
The Israeli prime minister disclosed a cancer diagnosis after earlier prostate surgery, with follow-up care revealing a tumor and radiation therapy underway.
In a Friday statement, the prime minister of Israel disclosed that he has been diagnosed with prostate cancer. He said he had previously undergone surgery in 2024 for an enlarged prostate, and follow-up care after that procedure revealed a tumor. He has since begun radiation therapy as part of his treatment plan. The disclosure marks a rare public update on the health of a long-serving leader, coming as the country navigates ongoing regional tensions and security challenges.
The prime minister noted that he delayed releasing the diagnosis by about two months, explaining that the timing would have been inappropriate amid the ongoing war with Iran. He stressed that the decision to speak publicly now was made to ensure transparency and to keep the public informed while continuing to perform his duties. The exact stage of the cancer, prognosis, and any further treatment steps were not detailed in the brief update.
Officials emphasized that the health update should not be viewed as a change in leadership or a stepping back from responsibilities. Netanyahu’s office said he remains active in his role and is receiving appropriate medical care, with medical teams monitoring his condition. Health experts highlighted that prostate cancer is a common and treatable disease, and radiation therapy is a standard course of care that can effectively manage many cases.
Analysts say the news could influence political discourse, particularly around transparency and leadership during a period of regional strain. However, they also caution that the government will likely balance reassuring the public about continuity with providing sufficient information about the treatment and timetable for any adjustments in schedule. As more details emerge, observers will watch for any shifts in public messaging or policy timing tied to the prime minister’s health status.
